Heparin ADE tracking

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 01/10/2024 - 14:28
#1
Laura Monroe-Duprey
Laura Monroe-Duprey's picture
Offline
Last seen: 1 day 23 hours ago
Joined: 06/28/2022 - 06:16
Heparin ADE tracking

We are in the middle of defining our heparin ADE metrics.
We were originally looking to capture the rate of heparin infusion patients who experienced a bleed plus those patients who experienced a DVT while on heparin infusion.
However we are finding this to be a difficult capture without a manual review.
I am interested to know what others are doing around an ADE metric for heparin ?
If you are capturing ADEs for heparin what is your definition?

Top